መነሻ › Multiple Myeloma › Wisconsin › Milwaukee
በMilwaukee፣ WI ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች
ለMultiple Myeloma የሚደረጉ 21 ጥናቶች በMilwaukee እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Milwaukee
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Medical College of Wisconsin, Milwaukee
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Medical College Of Wisconsin, Milwaukee
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
ተሳታዮችን በመፈለግ ላይደረጃ 4
- Froedtert Memorial, Milwaukee
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The Medical College of Wisconsin, Milwaukee
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Aurora Cancer Care Milwaukee, Milwaukee
- Aurora St. Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- እና 4 ተጨማሪ
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Medical College of Wisconsin, Milwaukee
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Medical College of Wisconsin, Milwaukee
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Milwaukee
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Aurora Cancer Care-Milwaukee, Milwaukee
- Ascension Southeast Wisconsin Hospital-Saint Joseph-Milwaukee, Milwaukee
- Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
- እና 13 ተጨማሪ
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Milwaukee
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MCW-Clinical Cancer Center at Froedtert Hospital Campus, Milwaukee
Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
ተሳታዮችን በመፈለግ ላይ
- Medical College of Wisconsin, Milwaukee
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Froedtert Memorial Lutheran Hospital, Milwaukee
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Medical College of Wisconsin, Milwaukee
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert and the Medical College of Wisconsin, Milwaukee
በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች
- New York City, NY60 ጥናቶች
- Boston, MA42 ጥናቶች
- Atlanta, GA41 ጥናቶች
- Houston, TX38 ጥናቶች
- Durham, NC37 ጥናቶች
- Nashville, TN32 ጥናቶች
- Denver, CO27 ጥናቶች
- Rochester, MN24 ጥናቶች
- St. Louis, MO24 ጥናቶች
- Columbus, OH24 ጥናቶች
- Baldwin Park, CA23 ጥናቶች
- Chicago, IL22 ጥናቶች
በMilwaukee ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር23 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር22 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)22 ጥናቶች
- የሳንባ ካንሰር21 ጥናቶች
- የፕሮስቴት ካንሰር20 ጥናቶች
- ፎሊኩላር ሊምፎማ19 ጥናቶች
- የፓንክሪያስ ካንሰር18 ጥናቶች
- ኖን-ሆጅኪን ሊምፎማ18 ጥናቶች
- የእንቁላል ካንሰር17 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ17 ጥናቶች
- በርኪት ሊምፎማ16 ጥናቶች
- የልብ ድካም16 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።